< Previous Page
Last October, he was benched in three of nine games and pinch-hit for in three others — after being removed from Game 1 of the AL championship series, he was caught flirting with fans in the stands. His next hit against a right-handed pitcher will be his first in 19 at-bats. He was 0 for 18 in the postseason against righties. With each of his outs, fans booed more loudly and were more decisively convinced that he was done as a player.
But there is no end with A-Rod.
And there’s little the Yankees can do about it — and the remaining $104 million of Rodriguez’s contract.
There was a time when Rodriguez was touted as the star who would restore credibility to the record book. Now MLB wants to throw the book at him.
And the Yankees might prefer it if he just goes away.
Even if MLB suspends Rodriguez for 50 or 100 games for his connection to Biogenesis of America and its founder Anthony Bosch, the Yankees can’t use that to void his contract because of language in baseball’s drug agreement.
Yankees ace CC Sabathia said he and his teammates are behind Rodriguez no matter what comes out of the investigation.
"There’ll be nothing but love and support in here," he said.
But the drug agreement does allow for a team to void a contract if it is proven that a player’s injury was a direct result of his use of performance enhancers.
The physician who performed Rodriguez’s surgery in January, Dr. Bryan Kelly of the Hospital for Special Surgery in New York, debunked that theory. He said the condition, known as femoral acetabular impingement, was caused by genes, not by steroids.
Next Page >
Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.